Dr. Daniel Lamar Cobb, MD

Dr. Cobb practices at Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System.

Dr. Cobb's NPI, 1457568644, was assigned on May 17, 2007. Dr. Cobb graduated from University of Alabama School of Medicine in 2004. Dr. Cobb holds Georgia license 060163.

Dr. Cobb's primary practice is Northeast Georgia Medical Center Gainesville, at 743 Spring Street, Gainesville, GA 30501 in Hall County. The practice phone is (770) 535-3553.

Dr. Cobb's primary practice is Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System. Dr. Cobb is also affiliated with Northside Hospital Forsyth. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Cobb to 2 more hospitals, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cobb practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cobb's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cobb is licensed in Georgia.

CMS data shows 11,860 Medicare services from Dr. Cobb across 20 procedure codes in 2024, for 868 Medicare patients. Medicare paid $202,230 for them. Every service was in an office.

CMS counts 868 Medicare patients who saw Dr. Cobb in 2024. The largest group is 65 to 74, with 426 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cobb's median patient age at 71, with 51% women.

In 2024, Dr. Cobb wrote 4,083 Medicare Part D claims for 679 patients. 82% of them were for generic drugs. CMS names the drug for 3,703 of them, across 73 drugs with 11 or more claims each, at $4,375,135 in total drug cost. In 2023, CMS named 3,762 claims across 79 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cobb for performance year 2024, reported as part of a group. Dr. Cobb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Cobb to 3 clinical trials. Conditions studied include Cataplexy, dopamine beta hydroxylase deficiency and Idiopathic Hypersomnia.

CMS Open Payments shows 1,610 general payments to Dr. Cobb from 82 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Abbvie Inc. paid the most, $58,674. It also lists 2 research payments totaling $1,747 from 2020 to 2021.

Dr. Cobb graduated from University of Alabama School of Medicine in 2004.